Skip to main content
SpringerLink
Log in

Erbliche Tumorerkrankungen: Patienten identifizieren, beraten und geeignete Angebote machen

Interview mit PD Dr. med. Kerstin Rhiem vom Zentrum Familiärer Brust- und Eierstockkrebs, Universitätsklinikum Köln, und Sprecherin der Arbeitsgemeinschaft Erbliche Tumorerkrankungen (AET) der Deutschen Krebsgesellschaft (DKG)

  • Interview
  • Published:
best practice onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Stoffel EM et al (2019) Evaluating susceptibility to pancreatic cancer: aSCO provisional clinical opinion. J Clin Oncol 37(2):153–164

    Article  Google Scholar 

  2. Wappenschmidt B et al (2020) Criteria of the German consortium for hereditary breast and ovarian cancer for the classification of germline sequence variants in risk genes for hereditary breast and ovarian cancer. Geburtshilfe Frauenheilkd 80(4):410–429

    Article  Google Scholar 

  3. Kast K et al (2016) Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53(7):465–471

    Article  CAS  Google Scholar 

  4. Moore K et al (2018) Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med 379(26):2495–2505

    Article  CAS  Google Scholar 

  5. Hauke J et al (2018) Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med 7(4):1349–1358

    Article  CAS  Google Scholar 

  6. Bick U, Helbich TH (2019) Follow-up of patients with breast cancer: imaging of local recurrence and distant metastases. In: Hodler J, Kubik-Huch RA, von Schulthess GK (Hrsg) IDKD springer series: diseases of the chest, breast, heart and vessels 2019-2022: diagnostic and interventional imaging. Springer Nature, Cham, S 167–178

    Chapter  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erbliche Tumorerkrankungen: Patienten identifizieren, beraten und geeignete Angebote machen. best practice onkologie 15, 492–497 (2020). https://doi.org/10.1007/s11654-020-00259-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-020-00259-8

Search

Navigation